For this purpose, it has been possible to create vesicles with signal regulatory protein alpha (SIRPα), which, in addition to lowering CD47 levels, increases the secretion of IFN-γ and conditions the infiltration of CD8+ and CD4+ T cells, further avoiding tumor growth [81]. The gene discussed is SIRPA; the disease is neoplasm.